My NCBISign In
Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase
Nancy J Ganson, Susan J Kelly, Edna Scarlett, John S Sundy, Michael S Hershfield
Arthritis Res Ther. 2006; 8(1): R12. Published online 2005 December 2. doi: 10.1186/ar1861
PMCID:
PMC1526556
Abstract Full Text PDF–943K

Is Cited by the Following 10 Articles in this Archive:

Role of the Methoxy Group in Immune Responses to mPEG-Protein Conjugates
Merry R. Sherman, L. David Williams, Monika A. Sobczyk, Shawnya J. Michaels, Mark G. P. Saifer
Bioconjug Chem. 2012 March 21; 23(3): 485–499. Published online 2012 February 14. doi: 10.1021/bc200551b
PMCID:
PMC3309606
Abstract Full Text PDF–4.1M Supplementary Material
Role of the Methoxy Group in Immune Responses to mPEG-Protein Conjugates
Merry R. Sherman, L. David Williams, Monika A. Sobczyk, Shawnya J. Michaels, Mark G. P. Saifer
Bioconjug Chem. 2012 March 21; 23(3): 485–499. Published online 2012 February 14. doi: 10.1021/bc200551b
PMCID:
PMC3309606
Abstract Full Text PDF–4.1M Supplementary Material
New advances in the treatment of gout: review of pegloticase
Mattheus K Reinders, Tim L Th A Jansen
Ther Clin Risk Manag. 2010; 6: 543–550. Published online 2010 October 27. doi: 10.2147/TCRM.S6043
PMCID:
PMC2988614
Abstract Full Text PDF–187K
Expression and Function of CXCL16 in a Novel Model of Gout
Jeffrey H. Ruth, Monica D. Arendt, M. Asif Amin, Salahuddin Ahmed, Hubert Marotte, Bradley J. Rabquer, Charles Lesch, SolHee Lee, Alisa E. Koch
Arthritis Rheum. Author manuscript; available in PMC 2011 August 1.
Published in final edited form as: Arthritis Rheum. 2010 August; 62(8): 2536–2544. doi: 10.1002/art.27518
PMCID:
PMC2921006
Abstract Full Text PDF–2.6M
Treating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of uric acid as an antioxidant in vivo
Michael S. Hershfield, L. Jackson Roberts, II, Nancy J. Ganson, Susan J. Kelly, Ines Santisteban, Edna Scarlett, Denise Jaggers, John S. Sundy
Proc Natl Acad Sci U S A. 2010 August 10; 107(32): 14351–14356. Published online 2010 July 26. doi: 10.1073/pnas.1001072107
PMCID:
PMC2922538
Abstract Full Text PDF–411K
DELIVERY OF THERAPEUTIC PROTEINS
Dipak S. Pisal, Matthew P. Kosloski, Sathy V. Balu-Iyer
J Pharm Sci. Author manuscript; available in PMC 2011 June 1.
Published in final edited form as: J Pharm Sci. 2010 June; 99(6): 2557–2575. doi: 10.1002/jps.22054
PMCID:
PMC2857543
Abstract Full Text PDF–1.2M
Effects of Glycosylation on the Stability of Protein Pharmaceuticals
RICARDO J. SOLÁ, KAI GRIEBENOW
J Pharm Sci. Author manuscript; available in PMC 2010 April 1.
Published in final edited form as: J Pharm Sci. 2009 April; 98(4): 1223–1245. doi: 10.1002/jps.21504
PMCID:
PMC2649977
Abstract Full Text PDF–1.0M
Reassessing serum urate targets in the management of refractory gout: Can you go too low?
Michael S. Hershfield
Curr Opin Rheumatol. Author manuscript; available in PMC 2010 August 12.
Published in final edited form as: Curr Opin Rheumatol. 2009 March; 21(2): 138–142. doi: 10.1097/BOR.0b013e3283257b83
PMCID:
PMC2920449
Abstract Full Text PDF–284K
Developments in the scientific and clinical understanding of gout
Alexander So
Arthritis Res Ther. 2008; 10(5): 221. Published online 2008 October 10. doi: 10.1186/ar2509
PMCID:
PMC2592794
Abstract Full Text PDF–426K
Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout
Lisa Cammalleri, Mariano Malaguarnera
Int J Med Sci. 2007; 4(2): 83–93. Published online 2007 March 2.
PMCID:
PMC1838823
Abstract Full Text PDF–319K
You are here: NCBI > Literature > PubMed Central (PMC)
Write to the Help Desk